Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dahlof

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The American Journal of Cardiology|January 30, 1987
Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindololL Hansson, B Dahlof
Journal of Human Hypertension|October 1, 1994
Criteria for an informative trial of left ventricular hypertrophy regressionR B Devereux, B Dahlof
The American Journal of Cardiology|July 1, 1996
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)R B Devereux, B Dahlof, D Levy, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 28, 2012
NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onsetJ A Zivin, R Sehra, A Shoshoo, et al.
The American Journal of Cardiology|September 11, 1999
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study)V Palmieri, J N Bella, V DeQuattro, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The American Journal of Cardiology|January 30, 1987
Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindololL Hansson, B Dahlof
Journal of Human Hypertension|October 1, 1994
Criteria for an informative trial of left ventricular hypertrophy regressionR B Devereux, B Dahlof
The American Journal of Cardiology|July 1, 1996
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)R B Devereux, B Dahlof, D Levy, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 28, 2012
NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onsetJ A Zivin, R Sehra, A Shoshoo, et al.
The American Journal of Cardiology|September 11, 1999
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study)V Palmieri, J N Bella, V DeQuattro, et al.
Pageof 1